Why the study?
Does myoepicardial left ventricular lead implantation via minithoracotomy improve clinical and echocardiographic parameters in CRT patients with unfavorable coronary venous anatomy?
Does myoepicardial left ventricular lead implantation via minithoracotomy improve clinical and echocardiographic parameters in CRT patients with unfavorable coronary venous anatomy?
Myoepicardial LV lead implantation via minithoracotomy is a safe and effective alternative for CRT in patients with unfavorable coronary venous anatomy, leading to favorable clinical and echocardiographic responses.
Answers are grounded in this paper and cite their sources.
May support minithoracotomy LV lead placement in select CRT patients; hypothesis-generating and requires prospective trials before practice change.
Introduction/Objective. Numerous anomalies of the cardiac venous system prevent the optimal endovascular implantation of the left ventricular (LV) lead in more than 15% of patients with indication for cardiac resynchronization therapy (CRT). The endovenous approach in these patients can be one of the potential reasons for the large number of nonresponders reported in the literature. The purpose of this study was to analyze the results of an alternative myoepicardial approach to the stimulation of the left ventricle in CRT. Methods. From June 2014 to December 2015 at the Department of Cardiac Surgery of the Clinical Centre of Serbia, 15 myoepicardial LV leads for CRT were implanted. Coronary sinus venography revealed thrombosis of the coronary sinus in nine patients, and unfavorable anatomy of the coronary venous system in six patients. In all patients, limited left thoracotomy was used as an approach to the lateral wall of the heart. Results. There were no major surgical complications and no lethal hospital outcomes. In a six-month follow-up period we registered a significant increase in the length of the six-minute walk test (for an average of 57.9 m), reduction of the QRS complex width (to 26.25 ms), increase in left ventricular ejection fraction (12.2%), and reduction of mitral regurgitation for 1+. Based on all the parameters, it was concluded that all patients responded favorably to the applied CRT. Conclusion. Closer cooperation between cardiologists and cardiac surgeons in identifying patients who would benefit the most from a myoepicardial approach for LV stimulation is necessary in order to attempt to reduce the nonresponder rate.
No takes yet. Share an insight, caveat, or question.
Savic et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: